Latest period
$154.00M
YoY change
-3.8%
5Y CAGR
-6.2%
Peak year (2020)
$281.00M
Latest annual
$204.00M
Stock-Based Compensation history chart for Centene (CNC) from 2000 to 2025
Latest: $204.00M
Stock-Based Compensation growth chart for Centene (CNC) from 2000 to 2025
Latest: -3.8%
Stock-Based Compensation history table for Centene (CNC) from 2000 to 2025
| 2025 | $204.00M | -3.8% | −$8.00M | ||
| 2024 | $212.00M | -1.9% | −$4.00M | ||
| 2023 | $216.00M | -7.7% | −$18.00M | ||
| 2022 | $234.00M | +15.3% | +$31.00M | ||
| 2021 | $203.00M | -27.8% | −$78.00M | ||
| 2020 | $281.00M | +58.8% | +$104.00M | ||
| 2019 | $177.00M | +22.1% | +$32.00M | ||
| 2018 | $145.00M | +7.4% | +$10.00M | ||
| 2017 | $135.00M | -8.8% | −$13.00M | ||
| 2016 | $148.00M | +108.5% | +$77.00M | ||
| 2015 | $71.00M | +47.9% | +$23.00M | ||
| 2014 | $48.00M | +30.9% | +$11.34M | ||
| 2013 | $36.66M | +44.7% | +$11.32M | ||
| 2012 | $25.33M | +39.4% | +$7.16M | ||
| 2011 | $18.17M | +31.0% | +$4.30M | ||
| 2010 | $13.87M | -5.2% | −$760.00K | ||
| 2009 | $14.63M | -4.5% | −$694.00K | ||
| 2008 | $15.33M | -2.9% | −$453.00K | ||
| 2007 | $15.78M | +5.9% | +$877.00K | ||
| 2006 | $14.90M | +199.6% | +$9.93M | ||
| 2005 | $4.97M | +665.2% | +$4.32M | ||
| 2004 | $650.00K | +245.7% | +$462.00K | ||
| 2003 | $188.00K | — | +$188.00K | ||
| 2002 | $0.00 | — | $0.00 | ||
| 2001 | $0.00 | — | $0.00 | ||
| 2000 | $0.00 | — | — |
- 2025$204.00M-3.8%
- 2024$212.00M-1.9%
- 2023$216.00M-7.7%
- 2022$234.00M+15.3%
- 2021$203.00M-27.8%
- 2020$281.00M+58.8%
- 2019$177.00M+22.1%
- 2018$145.00M+7.4%
- 2017$135.00M-8.8%
- 2016$148.00M+108.5%
- 2015$71.00M+47.9%
- 2014$48.00M+30.9%
- 2013$36.66M+44.7%
- 2012$25.33M+39.4%
- 2011$18.17M+31.0%
- 2010$13.87M-5.2%
- 2009$14.63M-4.5%
- 2008$15.33M-2.9%
- 2007$15.78M+5.9%
- 2006$14.90M+199.6%
- 2005$4.97M+665.2%
- 2004$650.00K+245.7%
- 2003$188.00K—
- 2002$0.00—
- 2001$0.00—
- 2000$0.00—
Stock-Based Compensation values are taken from Centene's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Centene (CNC)
Stock-Based Compensation for Centene (CNC): headline value $154.00M · YoY -3.8%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Centene (CNC) reported stock-based compensation of $204.00M – edged down 3.8% year-over-year.
Across 2020–2025 (5 years), Centene stock-based compensation produced a CAGR of -6.2% – with a net decline across the window.
Across the available history, stock-based compensation reached its high of $281.00M in 2020 and its low of $0.00 in 2000.
Centene Stock-Based Compensation by Year
Centene Stock-Based Compensation 2025: $204.00M
Centene stock-based compensation in 2025 was $204.00M, edged down 3.8% below 2024.
Centene Stock-Based Compensation 2024: $212.00M
2024's stock-based compensation for Centene came in at $212.00M, edged down 1.9% below 2023.
Centene Stock-Based Compensation 2023: $216.00M
Centene posted stock-based compensation of $216.00M in 2023, declined 7.7% below 2022.
Centene Stock-Based Compensation 2022: $234.00M
In 2022, Centene reported stock-based compensation of $234.00M, grew 15.3% from 2021.
Centene Stock-Based Compensation 2021: $203.00M
Centene stock-based compensation in 2021 was $203.00M.
See more financial history for Centene (CNC).
Sector peers by Stock-Based Compensation
Healthcare peers of Centene (CNC), ranked by their latest stock-based compensation
| $1.35B | |
| $971.00M | |
| $955.00M | |
| $626.00M | |
| $0.00 | |
| $0.00 | |
| $0.00 | |
| $0.00 |
- $1.35B
- $971.00M
- $955.00M
- $626.00M
- $0.00
- $0.00
- $0.00
- $0.00
Frequently asked questions
Centene (CNC) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation